Acer Therapeutics Inc
ACER
ACER was delisted on the 8th of November, 2023.
16 hedge funds and large institutions have $919K invested in Acer Therapeutics Inc in 2014 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
11% less funds holding
Funds holding: 18 → 16 (-2)
30% less capital invested
Capital invested by funds: $1.32M → $919K (-$397K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$44.4K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$14.7K |
| 3 |
Citigroup
New York
|
+$145 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
-$99K |
| 2 |
MC
Moors & Cabot
Boston,
Massachusetts
|
-$13.9K |
| 3 |
Goldman Sachs
New York
|
-$3.18K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2K |
ACER Hedge Fund Activity: Q4 2014 in Review
16 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q4 2014, worth a combined $919K — down 30% from $1.32M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ACER and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 3 added.
The largest buyer was Citadel Advisors, adding an estimated $44.4K. The largest seller was Shepherd Kaplan Krochuk, exiting entirely with an estimated $99K sold.
- 16 institutional investors held Acer Therapeutics Inc (ACER) as of Q4 2014, down from 18 in Q3 2014.
- Funds reported $919K of Acer Therapeutics Inc stock for Q4 2014, down 30% quarter-over-quarter.
- 1 fund opened new Acer Therapeutics Inc positions in Q4 2014 and 2 closed out, a net change of -1 holder.
- The largest Acer Therapeutics Inc buyer in Q4 2014 was Citadel Advisors, an estimated $44.4K added.
- The largest Acer Therapeutics Inc seller in Q4 2014 was Shepherd Kaplan Krochuk, an estimated $99K sold.
Based on aggregated 13F filings for Q4 2014.